Google
×
Altamira Therapeutics is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
People also ask
Auris Medical is a biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous ...
Feb 13, 2019 · Auris Health is a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently ...
Jul 16, 2021 · Auris Medical is dedicated to developing therapeutics that address important unmet medical needs. ... The Company was founded in 2003 and is ...
operates as a pharmaceutical company. The Company specializes in the development of cochlear therapies for the treatment of acute inner ear tinnitus and acute sensorineural hearing loss from acute acoustic trauma, deafness, and in middle and innerear surgery. Altamira Therapeutics markets its products worldwide.
Jun 3, 2021 · The Company intends to focus on the development of RNA therapeutics while in the medium term aiming to spin off or divest its existing assets in neurotology, ...
Apr 8, 2021 · Auris Medical is a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, ...
Auris Medical Holding

Auris Medical Holding

Pharma company · altamiratherapeutics.com
Headquarters: Zug, Switzerland
Founded: 2003
Jun 3, 2021 · Auris Medical as we know it will become obsolete as it changes its name to Altamira Therapeutics and changes its trading symbol to "CYTO," the ...
... Auris Medical Limited Bayview House, 49 North Strand Road DUBLIN Dublin 3 IRELAND. Phone 1: +353 766 15 46 75. Contact email: auris@aurismedical.com.